Skip to main content
. 2023 Jan 6;324(3):H330–H337. doi: 10.1152/ajpheart.00708.2022

Table 1.

Patient demographics

Non-CAD
CAD
Sample Characteristics (n = 152) Male Females < 40 yr Females ≥40 yr P value Female Male P value
n 22 35 52 10 27
Age 53.1 ± 10.8 35.5 ± 3.1 54.0 ± 10.6 <0.001
0.714*/<0.001‡
62.8 ± 8.31 67.0 ± 7.4 0.148
BMI 33.7 ± 9.2 29.2 ± 7.2 29.4 ± 7.0 0.116
0.030*/0.072‡
32.0 ± 10.9 30.5 ± 4.4 0.592
Race, n, % 1 (4.5) 2 (6.1) 0 0.419 0 0 0.006
 Asian 0 4 (12.1) 5 (9.6) 4 (40) 1 (3.7)
 African American 20 (90.9) 28 (78.8) 46 6 (60) 24 (88.9)
 Caucasian 0 1 (3.0) (88.5) 0 0
 Hispanic 1 (4.5) 0 1 (1.9) 0 2 (7.4)
 Unknown 0 0
Hypertension, n, % 3 (13.6) 0 6 (11.5) 0.094 6 (60) 16 (59.3) 0.967
Diabetes, n, % 1 (4.5) 2 (5.7) 2 (3.8) 0.920 5 (50) 11 (40.7) 0.614
Hyperlipidemia, n, % 0 1 (2.9) 3 (5.7) 0.460 4 (40) 15 (55.6) 0.401
Congestive heart failure, n, % 0 0 0 2 (20) 3 (11.1) 0.482
Smoker, n, % 2 (9.1) 1 (2.9) 0 0.092 4 (40) 3 (11.1) 0.046

Values are means ± SD or n (%); n, number of subjects. One-way ANOVA (non-CAD, top, P value) or two-tailed independent samples t test [male vs. female <40 yr (*) or ≥40 yr (‡); CAD males vs. females] was used for comparing age and BMI between groups. Pearson’s χ2 test was used for all remaining categorical variables. Boldface indicates significance.